Rupert Vessey - Oct 30, 2025 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Director
Signature
/s/ Andrew Nick as Attorney-in-Fact for Rupert Vessey pursuant to Power of Attorney previously filed
Stock symbol
TECH
Transactions as of
Oct 30, 2025
Transactions value $
$0
Form type
4
Date filed
11/3/2025, 05:23 PM
Previous filing
Oct 28, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Vessey Rupert Director 614 MCKINLEY PL NE, MINNEAPOLIS /s/ Andrew Nick as Attorney-in-Fact for Rupert Vessey pursuant to Power of Attorney previously filed 2025-11-03 0001677618

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Award $0 +1.64K +17.55% $0.00 11K Oct 30, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Options (Right to Buy) Award $0 +3.78K $0.00 3.78K Oct 30, 2025 Common Stock 3.78K $60.96 Direct F1
holding TECH Stock Options (Right to Buy) 8.04K Oct 30, 2025 Common Stock 8.04K $50.41 Direct
holding TECH Stock Options (Right to Buy) 2.35K Oct 30, 2025 Common Stock 2.35K $52.32 Direct
holding TECH Stock Options (Right to Buy) 6.03K Oct 30, 2025 Common Stock 6.03K $63.92 Direct
holding TECH Stock Options (Right to Buy) 2.53K Oct 30, 2025 Common Stock 2.53K $128.81 Direct
holding TECH Stock Options (Right to Buy) 3.46K Oct 30, 2025 Common Stock 3.46K $73.94 Direct
holding TECH Stock Options (Right to Buy) 3.94K Oct 30, 2025 Common Stock 3.94K $61.51 Direct
holding TECH Stock Options (Right to Buy) 3.51K Oct 30, 2025 Common Stock 3.51K $68.37 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.